The role of multiploidy as unfavourable prognostic variable in colorectal cancer

Anticancer Research

Volumn 18, Issue 3 B, 1998, Pages 1957-1965

  Cosimelli, Maurizio ^a   D'agnano, Igea ^b   Tedesco, Manfredo ^a   D'angelo, Carmen ^a   Botti, Claudio ^a   Giannarelli, Diana ^a   Vasselli, Stefania ^a   Cavaliere, Francesco ^a   Zupi, Gabriella ^a   Cavaliere, Renato ^a  

^a REGINA ELENA NATIONAL CANCER INSTITUTE   (Italy)

^b CNR   (Italy)

Author keywords

Colorectal cancer; Multiploidy; Prognosis

Indexed keywords

CELL DNA;

ADULT; AGED; ANEUPLOIDY; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL CYCLE S PHASE; CELL PROLIFERATION; COLORECTAL CANCER; DIPLOIDY; FEMALE; FLOW CYTOMETRY; FOLLOW UP; HIGH RISK POPULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; POLYPLOIDY; PRIORITY JOURNAL; PROGNOSIS; COLORECTAL TUMOR; DISEASE FREE SURVIVAL; GENETICS; MIDDLE AGED; PROSPECTIVE STUDY; TIME;

ANEUPLOIDY; COLORECTAL NEOPLASMS; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; PROSPECTIVE STUDIES; TIME FACTORS;

EID: 14444284802     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Armitage NC, Robins RA, Evans DV et al: The influence of tumor DNA abnormalities in colorectal cancer. Br J Surg 72: 828-830, 1985.
2. Kokal W, Sheibani K, Terz J, Harada R: Tumor DNA content in the prognosis of colorectal carcinoma. JAMA 225: 3123-3127, 1986.
3. Scott NA, Rainwater LM, Wieand HS et al: The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable rectal carcinomas. Dis Colon Rectum 30: 513-520, 1987.
4. Scott NA, Wieand HS, Moertel CG et al: Colorectal cancer. Dukes stage, tumor site, preoperative plasma CEA level, and patient prognosis related to tumor DNA ploidy pattern. Arch Surg 122: 1375-1379, 1987.
5. Quirke P, Dixon M, Clayden A et al: Prognostic significance of DNA aneuploidy cell proliferation in rectal adenocarcinoma. J Pathol 151: 285-291, 1987.
6. Bauer KD, Lincoln S, Vera-Roman J et al: Prognostic implications of proliferative ativity and DNA aneuploidy in colonie adenocarcinomas. Lab Invest 57: 329-335, 1987.
7. Schutte B, Reynders M, Wiggers T et al: Retrospective analysis of the prognostic significance of DNA content and proliferative activity in large bowel carcinoma. Cancer Res 47: 329-335, 1987.
8. Goh HS, Jass JR, Alkin WS et al: Value of flow cytometric determination of ploidy as a guide to prognosis in rectal cancer. A multivariate analysis. Int J Colorectal Dis 2: 17-21, 1987.
9. Jones DJ, Moore M, Schofield PF: Prognostic significance of DNA ploidy in colorectal cancer: a prospective flow cytometric study. Br J Surg 75: 28-33, 1988.
10. Wiggers T, Arends J, Schutte B et al: A multivariate analysis of pathologic prognostic indicators in large bowel cancer. Cancer 61: 386-395, 1988.
11. Fisher E, Siderits R, Sass R, Fisher B: Value of assessment of ploidy in rectal cancers. Arch Path Lab Med 113: 525-528, 1989.
12. Halvorsen T, Johannesen E. DNA ploidy, tumor site, and prognosis in colorectal cancer: A flow cytometric study of paraffin embedded tissue. Scand J Gastroenterol 25: 141-148, 1990.
13. Visscher DW, Zarbo RJ, Ma CK et al: Flow cytometric DNA and clinicopathologic analysis of Dukes'A and B colonie adenocarcinomas: A retrospective study. Modern Pathol 3: 709-712, 1990.
14. Harlow S, Eriksen B, Poggensee L et al: Prognostic implications of proliferative activity and DNA aneuploidy in Astler-Coller Dukes stage C colonic adenocarcinomas. Cancer Res 51: 2403-2409, 1991.
15. Witzig T, Loprinzi C, Gonchoroff N et al: DNA ploidy and cell kinetic measurements as predictors of recurrence and survival in stages B2 and C colorectal adenocarcinomas. Cancer 68: 879-888, 1991.
16. Takanishi DM, Hart J, Covarelli P et al: Ploidy as a prognostic feature in colonie adenocarcinoma. Arch Surg 131: 587-592, 1996.
17. Giaretti W, Danova M, Geido E et al: Flow cytometric DNA index in the prognosis of colorectal cancer. Cancer 67: 1921-1927, 1991.
18. Chapman MAS, Hardcastle JD, Armitage NCM: Five-year prospective study of DNA tumor ploidy and colorectal cancer survival. Cancer 76: 383-387, 1995.
19. Lichtman SM, Mendel F, Hoexter B et al: Prospective analysis of colorectal carcinoma. Determination of an age-site and stage relationship and the correlation of DNA index with clinicopathologic parameters. Dis Col Rectum 37: 1286-1290, 1994.
20. Wolley RC, Schreiber K, Koss LG et al: DNA distribution in human colon carcinomas and its relationship to clinical behaviour. J Natl Cancer Inst 69: 15-22, 1982.
21. Emdin SO, Stenling R, Roos G. Prognostic value of DNA content in colorectal carcinoma. Cancer 60: 1282-1287, 1987.
22. Enker WE, Kimmel M, Cibes ES et al: DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 83: 701-707, 1991.
23. Tomoda H, Kakeji Y, Furusawa M: Prognostic significance of flow cytometric analysis of DNA content in colorectal cancer: a prospective study. J Surg Oncol 53: 144-148, 1993.
24. Melamed MR, Enker WE, Banner P et al: Flow cytometry of colorectal carcinoma with 3-year follow-up. Dis Colon Rectum 29: 184-186, 1986.
25. Rognum T, Lund E, Meling G, Langmark F: Near diploid large bowel carcinomas have better five-year survival than aneuploid ones. Cancer 68: 1077-1081, 1991.
26. Albe X, Vassilakos P, Helfer-Guarnori K et al: Independent prognostic value of ploidy in colorectal cancer: a prospective study using image cytometry. Cancer 66: 1168-1175, 1990.
27. Dunning D, Senegore AJ, Warzynski MJ: S phase and ploidy analysis of colorectal cancer. Dis Colon Rectum 38: 38 (abstract), 1995.
28. Bauer KD, Bagwell CB, Giaretti W et al: Consensus review of the clinical utility of DNA flow cytometry in colorectal cancer. Cytometry 14: 486-491, 1993.
29. Hiddeman W, von Bassewitz DB, Kleinemeier HJ et al: DNA stemline heterogeneity in colorectal cancer. Cancer Res 58: 258-263, 1986.
30. Petersen SE, Lorentzen M, Bichel P: A mosaic subpopulation structure of human colorectal carcinomas demonstrated by flow cytometry. In: Laerum OD, Lindmo T, Thorud E, eds. Cytometry, 4th ed, Universitetsforleget, Bergen, 412-416, 1980.
31. Rognum TO, Thorud E, Elgjo K et al: Large-bowel carcinomas with different ploidy, related to secretory component, Ig-A and CEA and plasma. Br J Cancer 45: 921-934, 1982.
32. Tribukait B, Hammarberg C, Rubio C: Ploidy and proliferation patterns in colorectal adenocarcinomas related to Dukes'classification and to histopathological differentiation. Acta Pathol Microbiol Scand 91: 89-95, 1983.
33. Frankjurt OS, Slocum HK, Rustum YM et al: Flow cytometric analysis of DNA aneuploidy in primary and metastatic human solid tumors. Cytometry 5: 71-80, 1984.
34. Scott NA, Grande JP, Weiland LH et al: Flow cytometric DNA patterns from colorectal cancers. How reproducible are they? Mayo Clin Proc 62: 331-337, 1987.
35. D'Agnano I, Cosimelli M, La Pera A et al: Flow cytometric analysis of DNA content and cell kinetics in colorectal carcinoma. Anticancer Res 13: 699-704, 1993.
36. Silvestrini R, D'Agnano I, Faranda A et al: Flow cytometric analysis of ploidy in colorectal cancer: a multicentric experience. Br J Cancer 67: 1042-1046, 1993.
37. Enker WE, Kimmel M, Cibas ES et al: DNA/RNA content and proliferative fractions of colorectal carcinomas: a five-year prospective study relating flow cytometry to survival. J Natl Cancer Inst 83: 701-708, 1991.
38. Lindmark G, Gerdin B, Pahlman L et al: Prognostic predictors in colorectal cancer. Dis Colon Rectum 37: 1219-1227, 1994.
39. Bosari S, Lee AKC, Wiley BD et al: Flow cytometric and image analyses of colorectal adenocarcinomas. A comparative study with clinical correlations. Am J Clin Pathol 99: 187-194, 1993.
40. Cavaliere F, Guadagni F, D'Agnano I et al: Biologic and clinical correlations among ploidy, cell kinetics, and the Tumor-Associated and Glycoprotein-72 tissue expression in colorectal cancer: preliminary findings. Dis Colon Rectum 37: 24-29, 1994.
41. Lampariello F, Sebastiani G, Cordelli E and Spano M: Modeling fluorescence dispersion in flow cytometric DNA histograms. Cytometry 12: 343-349, 1991.
42. D'Agnano I, Bucci B, Mottolese M et al: DNA ploidy, cell kinetics, epidermal growth factor receptor and HER2/neu oncoprotein expression in primary operable breast cancer. Ann NY Acad Sci 784: 472-481, 1996.
43. Cox DR, Oakes D. Analysis of survival data. London: Chapman and Hall, 1984.
44. Cox DR. Regression models and life tables. J Roy Statist Soc 34: 187-220, 1972.
45. Mulder JWR, Baas IO, Polak MN et al: Evaluation of p53 protein expression as a marker for long-term prognosis in colorectal carcinoma. Br J Cancer 71: 1257-1262, 1995.
46. Smith DR, Ji CY and Goh HS: Prognostic significance of p53 overexpression and mutation in colorectal adenocarcinomas. Br J Cancer 72: 216-223, 1996.
47. Moran MR, Rothenberger DA, Gallo RA et al: Multifactorial analysis of local recurrences in rectal cancer, including DNA ploidy studies: a predictive model. World J Surg 17: 801-805, 1993.
48. Moertel CG, Fleming TR, MacDonald JS et al: Fluorouracil plus Levamisole as effective adjuvant therapy after resection of stage III colon carcinoma: a final report. Ann Intern Med 122: 321-326, 1995.
49. Piedbois P, Buise M, Gray R et al: Portal vein infusion is an effective adjuvant treatment for patients with colorectal cancer. Proceedings ASCO 1995; 192, no. 444.
50. Chari RS, Tyler DS, Anscher MS et al: Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg 221: 778-787, 1995.
51. Rich TA, Skibber JM, Ajany JA et al: Preoperative infusional chemoradiation therapy for stage T3 rectal cancer. Int J Radiat Oncol Biol Phys 32: 1025-1029, 1995.
52. Stryker SJ, Kiel KD, Rademaker A et al: Preoperative 'chemoradiation' for stages II and III rectal carcinoma. Arch Surg 131: 514-519, 1996.